Company: JUNS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010990
Chunk: 15

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 15
---
ENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

Note 6 – Stockholders’
Equity, continued

A summary of activity for the three months ended
March 31, 2025 is presented below:

Schedule of Stock Option
Activity

    Number of Options  
    Weighted Average Exercise Price  
    Weighted Average Contractual Term (Years)  
    Aggregate Intrinsic Value 
  
    Outstanding as of December 31, 2024  
     10,633,988  
     1.02  
     6.25  
    $102,921,147 
  
    Granted  
     -  
     -  

    Exercised  
     -  
     -  

    Forfeited  
     -  
     -  

    Outstanding as of March 31, 2025  
     10,633,988  
    $1.02  
     6.00  
    $405,750 
  
    Exercisable as of March 31, 2025  
     10,335,848  
    $1.01  
     5.93  
    $405,750 

The
following table summarizes information related to stock options outstanding as of March 31, 2025:

Schedule of Employee
Stock Options Outstanding

    Outstanding Options  
    Vested Options 
  
    Exercise Price  
    Number Outstanding at March 31,  2025   
    Weighted Average Remaining Life  
    Number Exercisable at March 31,  2025   
    Weighted Average Remaining Life 
  
    $0.01  
     675,000  
     0.75  
     675,000  
     0.75 
  
    $0.74  
     1,657,564  
     3.82  
     1,657,564  
     3.82 
  
    $0.80  
     2,783,239  
     4.04  
     2,783,239  
     4.04 
  
    $1.33  
     5,461,935  
     7.39  
     5,163,795  
     7